India’s Department of Biotechnology, Government of India to support scale up and production of cGMP batches of SARS-CoV-2…
Fort Lee, NJ, April 13, 2022 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc (NASDAQ: NVCT), (“Nuvectis”…
Urvashi Patel, Ph.D., as Vice President, Regulatory Affairs Stacey Bilinski, as Vice President, Clinical Operations…
Discontinued enrollment of Phase 1/2 trial of ONCT-216 in Ewing sarcoma Resources will be primarily…
MONTREAL, April 13, 2022 (GLOBE NEWSWIRE) — ExCellThera Inc. (ExCellThera), an advanced clinical-stage biotechnology company…
VLN® Reduced Nicotine Content Cigarettes Launch in Chicagoland Pilot VLN® 95% reduced nicotine content cigarettes…
Renibus Therapeutics granted patent approval for the novel aqueous iron composition of RBT-3, a product…
Second U.S. orphan drug designation for efzofitimod clinical program SAN DIEGO, April 13, 2022 (GLOBE…
Provides Access to Additional Capital to Support Growth WARREN, N.J., April 13, 2022 (GLOBE NEWSWIRE)…
Publication describes critical interactions between cholix-based transport domain and endogenous intracellular trafficking pathways used by…
Dose increase of R327 Dose increase of R327 Highlights: 36 subjects successfully dosed in Phase…
BOSTON, April 13, 2022 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
MALVERN, Pa., April 13, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company…
This third collaboration with the Miami VA shows Longeveron’s commitment to improving the health of…
Webcast and Conference Call to Be Held Wednesday, April 27, 2022 at 8:30 a.m. EDT…
Additional data covered a variety of specialties, including vascular surgery, plastic surgery, general surgery, and…
– Q1 2022 consolidated sales grew 20%, supported by 35% growth in EGRIFTA SV®sales –…
The iSpecimen Marketplace Platform Now Provides Custom Sequencing for Cancer and COVID-19 Biofluid and Tissue…
Post-hoc analyses from Illuminate trial of sepofarsen demonstrate an encouraging efficacy signal when comparing active…
NEW YORK and VIENNA, Austria, April 13, 2022 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ:…